What is already known
- Non-selective muscarinic antagonists and ablation or functional
inhibition of striatal cholinergic interneurons inhibit
levodopa-induced dyskinesia
- Striatal M4 receptor activation reduces levodopa-induced dyskinesia in
mice and non human primates